D-0146-2020 Class II Terminated
FDA drug recall D-0146-2020 was initiated by Ingenus Pharmaceuticals Llc on Oct 9, 2019 and is designated Class II. Reason for recall: Crystallization: Presence of particulate matter identified as API crystallization The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 16485 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 23, 2019
- Initiation Date
- Oct 9, 2019
- Termination Date
- Dec 1, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16485 vials
Product description
Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only Ingenus Pharmaceuticals, LLC. Orlando, FL 32839
Reason for recall
Crystallization: Presence of particulate matter identified as API crystallization
Distribution pattern
U.S.A. Nationwide
Code information
Lot#: 18048, 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0146-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026